BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q2 2024 Earnings Call Transcript

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q2 2024 Earnings Call Transcript August 5, 2024

BioMarin Pharmaceutical Inc. misses on earnings expectations. Reported EPS is $0.535 EPS, expectations were $0.57.

Operator: Good afternoon, and welcome to the BioMarin Pharmaceuticals Second Quarter 2024 Conference Call. Please note that this call is being recorded. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer...